ANAPTYSBIO, INC - Common Stock, $0.01 par value (ANAB)

Historical Holders from Q1 2017 to Q3 2025

Symbol
ANAB on Nasdaq
CUSIP
032724106
Type / Class
Equity / Common Stock, $0.01 par value
Shares outstanding
27.7M
All holders as of September 30, 2025
Q3 2025
Total 13F shares, excl. options
31.6M
Holdings value
$969M
% of all portfolios
0.002%
Grand Portfolio weight change
0%
Number of holders
162
Number of buys
74
Number of sells
-73
Average Value change %
0%
Average buys %
+0%
Average sells %
-0.001%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of ANAPTYSBIO, INC - Common Stock, $0.01 par value (ANAB)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Point72 Asset Management, L.P. 7.7% +35% $40.7M $11.6M 2.37M +40% Point72 Asset Management, L.P. Mar 31, 2025
BlackRock, Inc. 6.2% -27.5% $32.6M -$11.1M 1.9M -25.4% BlackRock, Inc. Mar 31, 2025
MORGAN STANLEY 6.3% $37M 1.85M Morgan Stanley Jun 30, 2025
VANGUARD GROUP INC 5.23% +5.8% $30.8M $405K 1.54M +1.33% The Vanguard Group Jun 30, 2025
MILLENNIUM MANAGEMENT LLC 5.1% $28.9M 1.43M Millennium Management LLC Sep 16, 2025
GOLDMAN SACHS GROUP INC 4.5% -14% $38.3M -$10.3M 1.25M -21.2% THE GOLDMAN SACHS GROUP, INC. Sep 30, 2025
First Light Asset Management, LLC 3.12% -57.4% $26.5M -$42.9M 865K -61.8% Mathew P. Arens Sep 30, 2025
FMR LLC 0.9% -88.3% $5.09M -$33.1M 254K -86.7% FMR LLC May 30, 2025

Institutional Holders of ANAPTYSBIO, INC - Common Stock, $0.01 par value (ANAB)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 31.6M $969M -$154M $30.62 162
2025 Q2 36.8M $816M -$61.5M $22.20 146
2025 Q1 40M $743M +$107M $18.59 150
2024 Q4 35.4M $469M -$87.9M $13.24 132
2024 Q3 33.6M $1.13B +$123M $33.50 162
2024 Q2 29.8M $747M +$16M $25.06 133
2024 Q1 28.8M $648M -$22.4M $22.52 103
2023 Q4 35.6K $762K $21.42 1
2023 Q3 30.3M $544M -$1.74M $17.96 115
2023 Q2 30.2M $614M -$16.3M $20.34 114
2023 Q1 31M $675M -$44.6M $21.76 109
2022 Q4 32.8M $1.02B -$10.6M $30.99 112
2022 Q3 32.6M $830M +$39.1M $25.51 106
2022 Q2 31M $630M +$27.6M $20.30 115
2022 Q1 29.6M $732M +$44.7M $24.74 122
2021 Q4 27.7M $964M +$8.82M $34.75 127
2021 Q3 27.5M $747M -$4.02M $27.12 122
2021 Q2 27.7M $719M -$34.3M $25.93 118
2021 Q1 29.1M $628M +$26.6M $21.55 116
2020 Q4 27.9M $601M -$16.4M $21.50 128
2020 Q3 27.2M $401M -$14.2M $14.75 123
2020 Q2 30M $670M -$15.3M $22.34 116
2020 Q1 29.2M $413M +$44.2M $14.13 109
2019 Q4 28.3M $459M -$241M $16.25 116
2019 Q3 29M $1.02B -$48.5M $34.99 118
2019 Q2 30.1M $1.7B +$126M $56.42 123
2019 Q1 29.1M $2.13B +$19.4M $73.05 127
2018 Q4 28.9M $1.85B +$3.29M $63.79 116
2018 Q3 26M $2.59B +$372M $99.77 125
2018 Q2 22.4M $1.59B +$106M $71.04 116
2018 Q1 24.3M $2.53B +$62.7M $104.08 133
2017 Q4 23.8M $2.39B +$693M $100.72 115
2017 Q3 17.6M $616M +$141M $34.95 69
2017 Q2 13.7M $328M -$8.74M $23.93 49
2017 Q1 13.8M $381M +$374M $27.75 48